Lung disease in primary antibody deficiency

The Lancet Respiratory Medicine

Volumn 3, Issue 8, 2015, Pages 651-660

  Verma, Nisha ^a   Grimbacher, Bodo ^a,b   Hurst, John R ^c  

^a ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; AZATHIOPRINE; CD40 ANTIGEN; CD40 LIGAND; CIPROFLOXACIN; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOSPORIN A; FC RECEPTOR; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2 ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INFLIXIMAB; INFLUENZA VACCINE; MACROLIDE; MANNOSE BINDING LECTIN; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE; PREDNISONE; RITUXIMAB; UNCLASSIFIED DRUG;

ATELECTASIS; AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOIMMUNITY; AUTOSOMAL DOMINANT DISORDER; B LYMPHOCYTE; BACTERIAL ARTHRITIS; BACTERIUM CULTURE; BRONCHIECTASIS; CANDIDA; CD4 CD8 RATIO; CD4 LYMPHOCYTE COUNT; CELL PROLIFERATION; COHORT ANALYSIS; COMMON VARIABLE IMMUNODEFICIENCY; COMPUTER ASSISTED TOMOGRAPHY; CONJUNCTIVITIS; COUGHING; CYTOMEGALOVIRUS; CYTOPENIA; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 DEFICIENCY; DETERIORATION; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DNA RECOMBINATION; DNA REPAIR; DRUG MEGADOSE; DYSPNEA; ENCEPHALITIS; ENTERITIS; ENTEROVIRUS INFECTION; ENZYME ACTIVITY; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GASTROINTESTINAL DISEASE; GOOD SYNDROME; GRANULOMATOUS LYMPHOCYTIC INTERSTITIAL LUNG DISEASE; HAEMOPHILUS INFLUENZAE; HERPES SIMPLEX VIRUS; HISTOLOGY; HUMAN; HUMORAL IMMUNE DEFICIENCY; HYPER IGM SYNDROME; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOGLOBULIN A DEFICIENCY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN G DEFICIENCY; IMMUNOGLOBULIN PRODUCTION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; INTERSTITIAL LUNG DISEASE; LIFE EXPECTANCY; LIVER GRANULOMA; LOWER RESPIRATORY TRACT INFECTION; LUNG BIOPSY; LUNG DISEASE; LUNG GRANULOMA; LUNG LAVAGE; LUNG TRANSPLANTATION; LYMPHADENOPATHY; LYMPHOCYTE PROLIFERATION; LYMPHOCYTOPENIA; LYMPHOCYTOSIS; LYMPHOID HYPERPLASIA; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MARGINAL ZONE LYMPHOMA; MICROBIOME; MORBIDITY; MORTALITY; MYCOSIS; NONHODGKIN LYMPHOMA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGANIZING PNEUMONIA; OSTEOMYELITIS; OTITIS MEDIA; OXYGEN SATURATION; PATHOGENESIS; PHOSPHOINOSITIDE 3 KINASE DELTA SYNDROME; PHYSIOTHERAPIST; PNEUMOCYSTIS JIROVECI; PNEUMONIA; POLYMERASE CHAIN REACTION; PREVALENCE; PRIMARY ANTIBODY DEFICIENCY; PRIORITY JOURNAL; QUALITY OF LIFE; RECURRENT DISEASE; REVIEW; RHINOVIRUS; RHINOVIRUS INFECTION; RISK FACTOR; SINUSITIS; SKIN INFECTION; SPECIFIC ANTIBODY DEFICIENCY; SPIROMETRY; SPLENOMEGALY; STAPHYLOCOCCUS; STREPTOCOCCUS PNEUMONIAE; THYMOMA; TREATMENT RESPONSE; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; VACCINATION; VIRUS INFECTION; X LINKED AGAMMAGLOBULINEMIA; ADULT; COMPLICATION; IMMUNOLOGY; RESPIRATORY TRACT INFECTION;

ADULT; BRONCHIECTASIS; COMMON VARIABLE IMMUNODEFICIENCY; HUMANS; LUNG DISEASES; RESPIRATORY TRACT INFECTIONS; RISK FACTORS;

EID: 84939473218     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(15)00202-7     Document Type: Review

References (72)

1. Palmer DS, O'Toole J, Montreuil T, et al. Screening of Canadian Blood Services donors for severe immunoglobulin A deficiency. Transfusion 2010, 50:1524-1531.
2. Eades-Perner AM, Gathmann B, Knerr V, et al. The European internet-based patient and research database for primary immunodeficiencies: results 2004-06. Clin Exp Immunol 2007, 147:306-312. the ESID Registry Working Party.
3. Winkelstein JA, Marino MC, Lederman HM, et al. X-linked agammaglobulinemia: report on a United States registry of 201 patients. Medicine (Baltimore) 2006, 85:193-202.
4. Lougaris V, Vitali M, Baronio M, et al. Autosomal recessive agammaglobulinemia: the third case of Igβ deficiency due to a novel non-sense mutation. J Clin Immunol 2014, 34:425-427.
5. Al-Saud BK, Al-Sum Z, Alassiri H, et al. Clinical, immunological, and molecular characterization of hyper-IgM syndrome due to CD40 deficiency in eleven patients. J Clin Immunol 2013, 33:1325-1335.
6. Report of an IUIS Scientific Committee. International Union of Immunological Societies. Clin Exp Immunol 1999, 118(suppl 1):1-28. Primary immunodeficiency diseases.
7. Park JH, Resnick ES, Cunningham-Rundles C Perspectives on common variable immune deficiency. Ann N Y Acad Sci 2011, 1246:41-49.
8. ESID Registry-Working Definitions for Clinical Diagnosis of PID (accessed Feb 4, 2015). http://esid.org/Working-Parties/Registry/Diagnosis-criteria.
9. Jorgensen GH, Gardulf A, Sigurdsson MI, et al. Clinical symptoms in adults with selective IgA deficiency: a case-control study. J Clin Immunol 2013, 33:742-747.
10. Ochs HD, Stiehm ER, Winkelstein JA, et al. Antibody deficiencies. Immunologic disorders in infants and children 2004, Elsevier, Philadelphia. 5th edn. H.D. Ochs, E.R. Stiehm, J.A. Winkelstein (Eds.).
11. Kelleher P, Misbah SA What is Good's syndrome? Immunological abnormalities in patients with thymoma. J Clin Pathol 2003, 56:12-16.
12. Angulo I, Vadas O, Garçon F, et al. Phosphoinositide 3-kinase δ gene mutation predisposes to respiratory infection and airway damage. Science 2013, 342:866-871.
13. Jou ST, Chien YH, Yang YH, et al. Identification of variations in the human phosphoinositide 3-kinase p110delta gene in children with primary B-cell immunodeficiency of unknown aetiology. Int J Immunogenet 2006, 33:361-369.
14. Lucas CL, Kuehn HS, Zhao F, et al. Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110δ result in T cell senescence and human immunodeficiency. Nat Immunol 2014, 15:88-97.
15. Kracker S, Curtis J, Ibrahim MA, et al. Occurrence of B-cell lymphomas in patients with activated phosphoinositide 3-kinase δ syndrome. J Allergy Clin Immunol 2014, 134:233-236.
16. Crank MC, Grossman JK, Moir S, et al. Mutations in PIK3CD can cause hyper IgM syndrome (HIGM) associated with increased cancer susceptibility. J Clin Immunol 2014, 34:272-276.
17. Kuehn HS, Ouyang W, Lo B, et al. Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4. Science 2014, 345:1623-1627.
18. Schubert D, Bode C, Kenefeck R, et al. Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations. Nat Med 2014, 20:1410-1416.
19. Maglione PJ, Overbey JR, Radigan L, Bagiella E, Cunningham-Rundles C Pulmonary radiologic findings in common variable immunodeficiency: clinical and immunological correlations. Ann Allergy Asthma Immunol 2014, 113:452-459.
20. Quinti I, Di Pietro C, Martini H, et al. Health related quality of life in common variable immunodeficiency. Yonsei Med J 2012, 53:603-610.
21. Hurst JR, Workman S, Garcha DS, Seneviratne SL, Haddock JA, Grimbacher B Activity, severity and impact of respiratory disease in primary antibody deficiency syndromes. J Clin Immunol 2014, 34:68-75.
22. Resnick ES, Moshier EL, Godbold JH, Cunningham-Rundles C Morbidity and mortality in common variable immune deficiency over 4 decades. Blood 2012, 119:1650-1657.
23. Maarschalk-Ellerbroek LJ, de Jong PA, van Montfrans JM, et al. CT screening for pulmonary pathology in common variable immunodeficiency disorders and the correlation with clinical and immunological parameters. J Clin Immunol 2014, 34:642-654.
24. Aghamohammadi A, Allahverdi A, Abolhassani H, et al. Comparison of pulmonary diseases in common variable immunodeficiency and X-linked agammaglobulinaemia. Respirology 2010, 15:289-295.
25. Gregersen S, Aaløkken TM, Mynarek G, et al. High resolution computed tomography and pulmonary function in common variable immunodeficiency. Respir Med 2009, 103:873-880.
26. Detková D, de Gracia J, Lopes-da-Silva S, et al. Common variable immunodeficiency: association between memory B cells and lung diseases. Chest 2007, 131:1883-1889.
27. Thickett KM, Kumararatne DS, Banerjee AK, Dudley R, Stableforth DE Common variable immune deficiency: respiratory manifestations, pulmonary function and high-resolution CT scan findings. QJM 2002, 95:655-662.
28. Gregersen S, Aaløkken TM, Mynarek G, et al. Development of pulmonary abnormalities in patients with common variable immunodeficiency: associations with clinical and immunologic factors. Ann Allergy Asthma Immunol 2010, 104:503-510.
29. Serra G, Milito C, Mitrevski M, et al. Lung MRI as a possible alternative to CT scan for patients with primary immune deficiencies and increased radiosensitivity. Chest 2011, 140:1581-1589.
30. Chen Y, Stirling RG, Paul E, Hore-Lacy F, Thompson BR, Douglass JA Longitudinal decline in lung function in patients with primary immunoglobulin deficiencies. J Allergy Clin Immunol 2011, 127:1414-1417.
31. Rich AL, Le Jeune IR, McDermott L, Kinnear WJ Serial lung function tests in primary immune deficiency. Clin Exp Immunol 2008, 151:110-113.
32. Menzin J, Sussman M, Munsell M, Zbrozek A Economic impact of infections among patients with primary immunodeficiency disease receiving IVIG therapy. Clinicoecon Outcomes Res 2014, 6:297-302.
33. Busse PJ, Razvi S, Cunningham-Rundles C Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency. J Allergy Clin Immunol 2002, 109:1001-1004.
34. Lucas M, Lee M, Lortan J, Lopez-Granados E, Misbah S, Chapel H Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years. J Allergy Clin Immunol 2010, 125:1354-1360. e4.
35. Orange JS, Grossman WJ, Navickis RJ, Wilkes MM Impact of trough IgG on pneumonia incidence in primary immunodeficiency: A meta-analysis of clinical studies. Clin Immunol 2010, 137:21-30.
36. Quinti I, Soresina A, Guerra A, et al. Effectiveness of immunoglobulin replacement therapy on clinical outcome in patients with primary antibody deficiencies: results from a multicenter prospective cohort study. J Clin Immunol 2011, 31:315-322. the IPINet Investigators.
37. Berger M Incidence of infection is inversely related to steady-state (trough) serum IgG level in studies of subcutaneous IgG in PIDD. J Clin Immunol 2011, 31:924-926.
38. Kainulainen L, Vuorinen T, Rantakokko-Jalava K, Osterback R, Ruuskanen O Recurrent and persistent respiratory tract viral infections in patients with primary hypogammaglobulinemia. J Allergy Clin Immunol 2010, 126:120-126.
39. Kralickova P, Mala E, Vokurkova D, et al. Cytomegalovirus disease in patients with common variable immunodeficiency: three case reports. Int Arch Allergy Immunol 2014, 163:69-74.
40. Pasteur MC, Bilton D, Hill AT British Thoracic Society guideline for non-CF bronchiectasis. Thorax 2010, 65(suppl 1):i1-58. the British Thoracic Society Bronchiectasis non-CF Guideline Group.
41. Hill AT, Routh C, Welham S National BTS bronchiectasis audit 2012: is the quality standard being adhered to in adult secondary care?. Thorax 2014, 69:292-294.
42. Gathmann B, Mahlaoui N, Gérard L, et al. Clinical picture and treatment of 2212 patients with common variable immunodeficiency. J Allergy Clin Immunol 2014, 134:116-126. the CEREDIH, the Dutch WIDthe Dutch WID, the European Society for Immunodeficiencies Registry Working Partythe European Society for Immunodeficiencies Registry Working Party.
43. Hampson FA, Chandra A, Screaton NJ, et al. Respiratory disease in common variable immunodeficiency and other primary immunodeficiency disorders. Clin Radiol 2012, 67:587-595.
44. Serisier DJ, Martin ML, McGuckin MA, et al. Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial. JAMA 2013, 309:1260-1267.
45. Wong C, Jayaram L, Karalus N, et al. Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial. Lancet 2012, 380:660-667.
46. Altenburg J, de Graaff CS, Stienstra Y, et al. Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial. JAMA 2013, 309:1251-1259.
47. Fevang B, Mollnes TE, Holm AM, et al. Common variable immunodeficiency and the complement system; low mannose-binding lectin levels are associated with bronchiectasis. Clin Exp Immunol 2005, 142:576-584.
48. Freiberger T, Grodecká L, Ravcuková B, et al. Association of FcRn expression with lung abnormalities and IVIG catabolism in patients with common variable immunodeficiency. Clin Immunol 2010, 136:419-425.
49. Kuruvilla M, de la Morena MT Antibiotic prophylaxis in primary immune deficiency disorders. J Allergy Clin Immunol Pract 2013, 1:573-582.
50. Pereira AC, Kokron CM, Romagnolo BM, et al. Analysis of the sputum and inflammatory alterations of the airways in patients with common variable immunodeficiency and bronchiectasis. Clinics (São Paulo) 2009, 64:1155-1160.
51. Kainulainen L, Nikoskelainen J, Vuorinen T, Tevola K, Liippo K, Ruuskanen O Viruses and bacteria in bronchial samples from patients with primary hypogammaglobulinemia. Am J Respir Crit Care Med 1999, 159:1199-1204.
52. Hurst JR Microbial dysbiosis in bronchiectasis. Lancet Respir Med 2014, 2:945-947.
53. Park JE, Beal I, Dilworth JP, Tormey V, Haddock J The HRCT appearances of granulomatous pulmonary disease in common variable immune deficiency. Eur J Radiol 2005, 54:359-364.
54. Maglione PJ, Ko HM, Beasley MB, Strauchen JA, Cunningham-Rundles C Tertiary lymphoid neogenesis is a component of pulmonary lymphoid hyperplasia in patients with common variable immunodeficiency. J Allergy Clin Immunol 2014, 133:535-542.
55. Wheat WH, Cool CD, Morimoto Y, et al. Possible role of Human Herpes Virus 8 in the lymphoproliferative disorders in common variable immunodeficiency. J Exp Med 2005, 202:479-484.
56. Marashi SM, Raeiszadeh M, Workman S, et al. Inflammation in common variable immunodeficiency is associated with a distinct CD8+ T cell response to cytomegalovirus. J Allergy Clin Immunol 2011, 127:1385-1393.
57. Boursiquot JN, Gérard L, Malphettes M, et al. Granulomatous disease in CVID: retrospective analysis of clinical characteristics and treatment efficacy in a cohort of 59 patients. J Clin Immunol 2013, 33:84-95. the DEFI study group.
58. STILPAD Observational Study, (accessed Feb 4, 2015). http://www.uniklinik-freiburg.de/cci/studien/stilpad.html.
59. Bouvry D, Mouthon L, Brillet PY, et al. Granulomatosis-associated common variable immunodeficiency disorder: a case-control study versus sarcoidosis. Eur Respir J 2013, 41:115-122. the Groupe Sarcoïdose Francophone.
60. Kollert F, Venhoff N, Goldacker S, et al. Bronchoalveolar lavage cytology resembles sarcoidosis in a subgroup of granulomatous CVID. Eur Respir J 2014, 43:922-924.
61. Naccache JM, Bouvry D, Valeyre D Bronchoalveolar lavage cytology resembles sarcoidosis in a subgroup of granulomatous CVID. Eur Respir J 2014, 43:924-925.
62. Gregersen S, Holm AM, Fevang B, et al. Lung disease, T-cells and inflammation in common variable immunodeficiency disorders. Scand J Clin Lab Invest 2013, 73:514-522.
63. Kohler PF, Cook RD, Brown WR, Manguso RL Common variable hypogammaglobulinemia with T-cell nodular lymphoid interstitial pneumonitis and B-cell nodular lymphoid hyperplasia: different lymphocyte populations with a similar response to prednisone therapy. J Allergy Clin Immunol 1982, 70:299-305.
64. Green H, Paul M, Vidal L, Leibovici L Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. Cochrane Database Syst Rev 2007, 3. CD005590.
65. Chase NM, Verbsky JW, Hintermeyer MK, et al. Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID). J Clin Immunol 2013, 33:30-39.
66. Davies CW, Juniper MC, Gray W, Gleeson FV, Chapel HM, Davies RJ Lymphoid interstitial pneumonitis associated with common variable hypogammaglobulinaemia treated with cyclosporin A. Thorax 2000, 55:88-90.
67. Thatayatikom A, Thatayatikom S, White AJ Infliximab treatment for severe granulomatous disease in common variable immunodeficiency: a case report and review of the literature. Ann Allergy Asthma Immunol 2005, 95:293-300.
68. Wehr C, Gennery AR, Lindemans C, et al. Multicenter experience in hematopoietic stem cell transplantation for serious complications of common variable immunodeficiency. J Allergy Clin Immunol 2015, 135:988-997. the Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation and the European Society for Immunodeficiency, e6.
69. Bates CA, Ellison MC, Lynch DA, Cool CD, Brown KK, Routes JM Granulomatous-lymphocytic lung disease shortens survival in common variable immunodeficiency. J Allergy Clin Immunol 2004, 114:415-421.
70. Burton CM, Milman N, Andersen CB, Marquart H, Iversen M Common variable immune deficiency and lung transplantation. Scand J Infect Dis 2007, 39:362-367.
71. Kaufman J, Komorowski R Bronchiolitis obliterans organizing pneumonia in common variable immunodeficiency syndrome. Chest 1991, 100:552-553.
72. Reichenberger F, Wyser C, Gonon M, Cathomas G, Tamm M Pulmonary mucosa-associated lymphoid tissue lymphoma in a patient with common variable immunodeficiency syndrome. Respiration 2001, 68:109-112.